logo logo
Search: Organ site Search: Tumor / Syndrome
WHO Classification of Tumours
Somatostatinoma, malignant
Region of the ampulla of Vater


A somatostatinoma is a functionally active and usually malignant endocrine tumour with evidence of D-cell differentiation and clinical symptoms reflecting the diverse pathophysiologic effects of chronic inappropriate secretion of somatostatin (hypersomatostatinemia; somatostatinoma syndrome)
Click for details
Ronald A. DeLellis, Ricardo V. Lloyd, Philipp U. Heitz, Charis Eng
World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of Endocrine Organs
IARC Press: Lyon 2004


Somatostatinomas account for between 1 to 2% of endocrine tumours of the gastroenteropancreaticohepatic (GEPH) axis and generally arise in adults. While some somatostatinomas are associated with neurofibromatosis type 1 (NF1) , multiple endocrine neoplasia (MEN1) and Von Hippel-Lindau syndromes , the etiology of their sporadic counterparts is unclear.

Commentary: Neuroendocrine tumours of the digestive system